Analyst Price Targets — FTRE
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| April 14, 2026 10:42 am | — | Barclays | $11.00 | $9.38 | TheFly | Fortrea price target lowered to $11 from $12 at Barclays |
| January 14, 2026 2:36 pm | — | Robert W. Baird | $19.00 | $17.05 | TheFly | Fortrea price target raised to $19 from $15 at Baird |
| January 9, 2026 12:09 pm | — | Mizuho Securities | $15.00 | $17.44 | TheFly | Fortrea price target raised to $15 from $13 at Mizuho |
| January 8, 2026 10:13 am | Jailendra Singh | Truist Financial | $22.00 | $17.49 | TheFly | Fortrea upgraded to Buy from Hold at Truist |
| January 6, 2026 10:29 am | — | Evercore ISI | $25.00 | $16.62 | TheFly | Fortrea upgraded to Outperform from In Line at Evercore ISI |
| December 18, 2025 12:06 pm | Ann Hynes | Mizuho Securities | $13.00 | $16.19 | TheFly | Fortrea price target raised to $13 from $11 at Mizuho |
| December 15, 2025 10:44 am | Luke Sergott | Barclays | $15.00 | $15.72 | TheFly | Fortrea upgraded to Equal Weight from Underweight at Barclays |
| December 11, 2025 10:02 am | — | Wedbush | $21.00 | $16.26 | StreetInsider | Citi Upgrades Fortrea (FTRE) to Buy |
| November 7, 2025 1:42 pm | Ann Hynes | Mizuho Securities | $11.00 | $10.70 | TheFly | Fortrea price target raised to $11 from $9 at Mizuho |
| November 6, 2025 5:37 pm | Elizabeth Anderson | Evercore ISI | $14.00 | $11.25 | TheFly | Fortrea price target raised to $14 from $11 at Evercore ISI |
Latest News for FTRE
Highlights: Designed to transform clinical trial operations for sponsors, sites and study teams Persona driven, AI-powered solutions automate workflows and streamline oversight to help improve trial speed, predictability and quality Builds on Fortrea's flagship platform Xcellerate® to deliver near-real-time, role-based insights DURHAM, N.C., April 07, 2026 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global…
SG Americas Securities LLC lifted its holdings in shares of Fortrea Holdings Inc. (NASDAQ: FTRE) by 245.9% in the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 153,228 shares of the company's stock after purchasing an additional 108,925 shares during the
Assenagon Asset Management S.A. lessened its position in Fortrea Holdings Inc. (NASDAQ: FTRE) by 57.6% during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 115,779 shares of the company's stock after selling 157,445 shares during the quarter. Assenagon Asset Management S.A. owned approximately
DURHAM, N.C., March 10, 2026 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization, today announced the granting of an inducement award of restricted stock units (“RSUs”) on March 10, 2026, to four newly hired employees. The award consisted of 130,000 RSUs that vest in three equal annual installments starting March 10, 2027, subject to the employee's continuous…
Citigroup Inc. trimmed its stake in Fortrea Holdings Inc. (NASDAQ: FTRE) by 49.7% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 294,470 shares of the company's stock after selling 290,848 shares during the period. Citigroup Inc. owned approximately 0.32% of
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for FTRE.
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.